18F-DCFPyL Positron Emission Tomography (PET) in Intermediate or High Risk Prostate Cancer
NCT04727736
·
clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
47
Enrollment
OTHER
Sponsor class
Stopped
Intervention became FDA-approved
Conditions
Prostate Cancer
Interventions
DRUG:
18F-DCFPyL
Sponsor
Ashok Muthukrishnan
Collaborators
[object Object]